About Neurotrack
Neurotrack is a Healthcare company based in Redwood City (United States) founded in 2012 by Elli Kaplan. Neurological disorders are diagnosed using eye-tracking assessment tools. It operates in the Healthcare and Technology sectors. Neurotrack has raised $57.81 million across 12 funding rounds from investors including Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine. Its chief executive, as recorded, is Elli Kaplan. Its website neurotrack.com draws about 11 thousand monthly visits. Neurotrack offers products and services including Cognitive Assessment and Cognitive Screening Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is NEUROTRACK TECHNOLOGIES, INC. Its competitors include C. Light Technologies, Oculogica and Neuralight; 3 of its 3 listed competitors have raised funding.
Company details
The company was founded in 2012 in Redwood City, United States, within the healthcare technology sector. Clinical assessment tools are provided for diagnosing neurological disorders, incorporating the Imprint Memory Assessment. This proprietary method employs computer vision algorithms and eye-tracking technology to evaluate behavioral biomarkers during cognitive and visual tests. Partnerships with pharmaceutical firms and researchers are maintained to facilitate clinical trial recruitment, assess drug efficacy, and advance drug development processes.
- Headquarters Redwood City, United States
- Founders Elli Kaplan
- SectorsHealthcareTechnology
- Email••••••••
- Website neurotrack.com
- Social LinkedIn X Facebook
- Legal Name Neurotrack Technologies, Inc.
- Total Equity Funding$57.81M (USD)
in 12 rounds
- Latest Funding Round$10M (USD), Series C
Nov 2022
- InvestorsKhosla Ventures
& 14 more
Products & Services of Neurotrack
Neurotrack offers a comprehensive portfolio of products and services, including Cognitive Assessment and Cognitive Screening Platform.
3-minute test for detecting cognitive impairment and dementia.
Platform integrating with EHR for early diagnosis of neurodegenerative conditions.
Funding Insights of Neurotrack
Neurotrack has successfully raised a total of $57.81M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $57.81M
- Total Rounds 12
- Last Round Series C — $10M
- First Round $100,000
(Aug 2012)
- Investors Count 15
Latest 10 of 12 funding rounds of Neurotrack with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $10M | Series C | – | – | – |
| Jun 2019 | $21.06M | Series C | – | Khosla Ventures | |
| Apr 2019 | $3.3M | Grant | – | – | |
| Apr 2019 | $3.27M | Grant | – | – | |
| Mar 2018 | $13.7M | Series B | – | Sozo Ventures | |
| May 2017 | $9.86M | Series B | – | Khosla Ventures | |
| Nov 2016 | $500,000 | Grant | – | – | |
| Dec 2014 | $1M | Series A | – | – | – |
| Aug 2014 | $150,000 | Grant | – | – | |
| Sep 2013 | $2M | Series A | – | Founders Fund, Social Capital | – |
15 investors in total: 14 institutional and 1 angel.
Investors in Neurotrack
Neurotrack has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada | rethinkimpact.com | Washington, Dc, United States | ||
AME Cloud Ventures is focused on investing in data-driven technology companies. | amecloudventures.com | Palo Alto, United States | ||
Venture capital firm focused on multiple sectors | sozoventures.com | Redwood City, United States | ||
Venture capital investments in technology and defense sectors. | foundersfund.com | |||
US focused VC firm investing in seed & growth stage companies | 2011 | socialcapital.com | Menlo Park, United States | |
Venture capital firm investing in AI and digital health startups based in San Francisco. | iseedvc.com | |||
Digital Health focused VC & Accelerator firm investing in the US | rockhealth.com | San Francisco, United States | ||
Life insurance company | 1902 | dai-ichi-life.co.jp | Chiyoda City, Japan | |
Life, nursing care, healthcare, and overseas insurance services are provided. | 2010 | sompo-hd.com | Tokyo, Japan |
Investor details for Neurotrack
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neurotrack
16 people are tracked at Neurotrack (8 in leadership, 3 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Elli Kaplan | Co-Founder & CEO | Leadership |
Emily Lapkin | Head Of Marketing And Communications | Leadership |
Teresa Dean | Director Of Product | Leadership |
Andrew Cunningham | Director Of Clinical Services | Leadership |
Katherine Wallace | Head of Compliance | Leadership |
Shane Gallagher | VP, Finance | Leadership |
Deb Dittberner | Medical Director | Leadership |
Jesus Villalobos | VP Of Strategic Partnerships | Leadership |
Elizabeth Buffalo | Scientific Co-Founder | Board & advisors |
Stewart Zola | Scientific Co-Founder | Board & advisors |
Cecilia Manzanares | Scientific Co-Founder | Board & advisors |
Meena Makihjani | Geriatrician | Team |
Daisy Wu | Senior Accountant | Team |
Vien Nguyen-Vu | GM - NTJ | Team |
Asha Robinson-Parks | Family Physician | Team |
Feyza Marouf | Geriatric Psychiatrist | Team |
Complete people profiles for Neurotrack
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neurotrack
3 dated milestones of Neurotrack across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Neurotrack is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Series C, of $10.0M.
Competitors of Neurotrack
Neurotrack has 3 listed competitors in our database, 3 of them funded. They include C. Light Technologies, Oculogica and Neuralight.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clighttechnologies.com | 2014 | Berkeley, United States | $2.5M | Eye-tracking devices are developed for neurodegenerative disease monitoring. | ||
| oculogica.com | 2013 | New York, United States | $21.98M | Eye-tracking technology is utilized to detect traumatic brain injuries. | ||
| neuralight.ai | 2021 | San Francisco, United States | $30.5M | AI-based neurological evaluation and assessment tool for diagonosis |
Detailed competitors of Neurotrack
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neurotrack
The website of Neurotrack (neurotrack.com) receives about 11.3K visits a month.
- Monthly visits11.3K
▲ 15.5% vs previous month
Websites whose visitors overlap most with Neurotrack. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| openplacement.com | 100% | 8.5K | #2,294,865 | View details | |
| bluezones.com | 98% | 321.2K | #159,625 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Neurotrack (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurotrack
Complete news archive for Neurotrack
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurotrack
Neurotrack was founded in 2012.
Neurotrack is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Elli Kaplan is the CEO of Neurotrack, as recorded in our data. They have also founded this company.
Neurotrack is a funded company, having raised a total of $57.81M across 12 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Aug 2012.
The company was founded in 2012 in Redwood City, United States, within the healthcare technology sector. Clinical assessment tools are provided for diagnosing neurological disorders, incorporating the Imprint Memory Assessment. This proprietary method employs computer vision algorithms and eye-tracking technology to evaluate behavioral biomarkers during cognitive and visual tests. Partnerships with pharmaceutical firms and researchers are maintained to facilitate clinical trial recruitment, assess drug efficacy, and advance drug development processes.
Neurotrack's top competitors include Neuralight, C. Light Technologies and Oculogica.
Neurotrack offers Cognitive Assessment and Cognitive Screening Platform.
Neurotrack has 15 investors. Key investors include Khosla Ventures, Social Capital, Johnson & Johnson Innovative Medicine, Sompo Holdings, and HHS.
Neurotrack operates through Neurotrack Technologies, Inc..